# Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial（HERO -aCKD）

> **NCT07027774** · PHASE4 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Wannan Medical College** · enrollment: 429 (estimated)

## Conditions studied

- Chronic Kidney Disease Stage 4

## Interventions

- **DRUG:** Henagliflozin 5 mg Group
- **DRUG:** Henagliflozin 10 mg Group
- **DRUG:** Conventional therapy group

## Key facts

- **NCT ID:** NCT07027774
- **Lead sponsor:** First Affiliated Hospital of Wannan Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 429 (ESTIMATED)
- **Last updated:** 2025-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07027774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07027774, "Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial（HERO -aCKD）". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07027774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*